---
$id: https://graph.org.ai/products/commodity/51241104
$type: Product
source: UNSPSC
code: "51241104"
title: "Brinzolamide"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brinzolamide

**UNSPSC Code**: 51241104
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a carbonic anhydrase inhibitor and anti-glaucoma agent with the molecular formula C12H21N3O5S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9451Z89515, chemically known as 2h-thieno(3,2-e)-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (r)- but generally known as brinzolamide, which bears US NIH Compound Identifier 68844. European Medicines Agency schedules Brinzolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05892MIG. The term BRINZOLAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 3 1997, List 38). World Health Organization schedules brinzolamide in its Anatomical Therapeutic Chemical (ATC) Classification. BRINZOLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brinzolamide under HS 29350090 and SITC 51580. As of Q4 2014, BRINZOLAMIDE remains the US FDA Preferred Term for this commodity. Brinzolamide bears US NLM identifiers UMLS ID C0673966 and NCI Concept Code C47420. SMILES: S1(=O)(=O)N(CC(NCC)C2C1SC(S(=O)(=O)N)C2)CCCOC.

